Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Arq. bras. oftalmol ; 86(1): 68-70, Jan.-Feb. 2023. tab, graf
Article in English | LILACS | ID: biblio-1403470

ABSTRACT

ABSTRACT This case report describes the clinical characteristics and ophthalmic management of a patient who developed corneal perforation due to severe enophthalmos consistent with "silent brain syndrome." A 27-year-old man with a history of congenital hydrocephalus and ventriculoperitoneal shunt was referred with complaints of "sinking of the eyeballs" and progressively decreasing vision in the left eye. Examination revealed severe bilateral enophthalmos in addition to superonasal corneal perforation with iris prolapse in the left eye. The patient underwent therapeutic keratoplasty the next day. Orbital reconstruction with costochondral graft and shunt revision of the intracranial hypotension were performed the next month to prevent further progression.


RESUMO Este relato de caso descreve as características clínicas e o manejo cirúrgico de um paciente que teve perfuração da córnea devido à enoftalmia grave consistente com a "síndrome do cérebro silencioso". Um homem de 27 anos com história de hidrocefalia congênita e derivação ventrículo-peritoneal foi encaminhado com queixas de "afundamento dos globos oculares" e diminuição progressiva da visão no olho esquerdo. O exame revelou enoftalmo bilateral importante, além de perfuração superonasal da córnea com prolapso iriano no olho esquerdo. A paciente foi submetida à ceratoplastia terapêutica no dia seguinte. Foi realizado no mês seguinte a reconstrução da órbita com enxerto costocondral e revisão do shunt para evitar progressão e piora do caso.


Subject(s)
Humans , Adult , Corneal Perforation , Brain , Corneal Perforation/surgery , Corneal Perforation/etiology
2.
Arq Bras Oftalmol ; 86(1): 68-70, 2023.
Article in English | MEDLINE | ID: mdl-35170650

ABSTRACT

This case report describes the clinical characteristics and ophthalmic management of a patient who developed corneal perforation due to severe enophthalmos consistent with "silent brain syndrome." A 27-year-old man with a history of congenital hydrocephalus and ventriculoperitoneal shunt was referred with complaints of "sinking of the eyeballs" and progressively decreasing vision in the left eye. Examination revealed severe bilateral enophthalmos in addition to superonasal corneal perforation with iris prolapse in the left eye. The patient underwent therapeutic keratoplasty the next day. Orbital reconstruction with costochondral graft and shunt revision of the intracranial hypotension were performed the next month to prevent further progression.


Subject(s)
Corneal Perforation , Humans , Adult , Corneal Perforation/etiology , Corneal Perforation/surgery , Brain
5.
Arq. bras. oftalmol ; 82(6): 471-475, Nov.-Dec. 2019. tab, graf
Article in English | LILACS | ID: biblio-1038699

ABSTRACT

ABSTRACT Purpose: To evaluate the biocompatibility of three-dimensional (3D) printed orbital spheres for evisceration. Materials: A total of 10 consecutive patients (eight females and two males; mean age, 46.8 ± 14.2 years) underwent evisceration of blind painful eyes. 3D spherical implants produced by a rapid prototype machine were used to restore orbital volume. The implants were produced from a commercially available photocurable resin (Fullcure®). Systemic toxicity was evaluated by comparing serum biochemical measurements (creatine phosphokinase, aspartate aminotransferase, alanine aminotransferase, albumin, creatinine, urea, alkaline phosphatase, and C-reactive protein) before and at 12 months after surgery. Local toxicity was assessed by the evaluation of signs of socket inflammation at the first postoperative month. Changes in implant size were determined by computed tomography scans at 2 and 12 months after surgery. Results: The postoperative evaluations were uneventful. The biochemical evaluation showed no significant changes after surgery. None of the patients presented signs of orbital implant inflammation, infection, exposure, or extrusion. Computed tomography scan evaluations revealed no changes in implant size. Conclusion: To the best of our knowledge, this is the first phase-1 clinical study to certify the biocompatibility of the Fullcure resin for orbital implants in humans. The 3D printing technology permits fast and accurate production of implants for this purpose.


RESUMO Objetivos: Avaliar a biocompatibilidade das esferas produzidas por impressora tridimensional em evisceração. Pacientes e métodos: Evisceração por olho cego doloroso foi realizada em 10 pacientes consecutivos (8 mulheres, idade média: 46.8 ± 14.2 anos). Os implantes esféricos foram produzidos pelo sistema de prototipagem rápida utilizando dados tridimensionais computadorizados. O material utilizado para produção dos implantes foi a resina fotocurável Fullcure®. A avaliação da toxicidade sistêmica do material foi realizada por meio da dosagem de marcadores bioquímicos (creatina fosfoquinase, aspartato aminotransferase, alanina aminotransferase, albumina, creatinina, ureia, fosfatase alcalina, e proteína C-reactiva) antes da cirurgia e aos 12 meses de pós-operatorio. A avaliação da toxicidade local foi realizada por meio do registro qualitativo dos sinais inflamatórios no lado operado durante o primeiro mês de pós-operatório. O tamanho dos implantes foi medido em tomografias computadorizadas (CT) aos 2 e 12 meses de pós-operatório. Resultados: A avaliação bioquímica mostrou que os marcadores estudados não sofreram alterações significativas após a cirurgia. Nenhum paciente apresentou sinais de inflamação atípica, infecção, exposição ou extrusão. A avaliação tomográfica não demonstrou mudanças nos tamanhos dos implantes. Conclusão: O presente trabalho é o primeiro estudo clínico realizado para atestar a biocompatibilidade dos implantes orbitais de resina fotocurável Fullcure. A produção dos implantes pela técnica de impressão tridimensional, utilizando essa resina, permite a disponibilização rápida e acurada do produto final


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Polymers/standards , Eye Evisceration/methods , Orbital Implants/standards , Printing, Three-Dimensional/standards , Postoperative Period , Prosthesis Design , Reference Values , Time Factors , Biocompatible Materials/standards , Materials Testing , Reproducibility of Results , Treatment Outcome
6.
Arq Bras Oftalmol ; 82(6): 471-475, 2019.
Article in English | MEDLINE | ID: mdl-31482968

ABSTRACT

PURPOSE: To evaluate the biocompatibility of three-dimensional (3D) printed orbital spheres for evisceration. MATERIALS: A total of 10 consecutive patients (eight females and two males; mean age, 46.8 ± 14.2 years) underwent evisceration of blind painful eyes. 3D spherical implants produced by a rapid prototype machine were used to restore orbital volume. The implants were produced from a commercially available photocurable resin (Fullcure®). Systemic toxicity was evaluated by comparing serum biochemical measurements (creatine phosphokinase, aspartate aminotransferase, alanine aminotransferase, albumin, creatinine, urea, alkaline phosphatase, and C-reactive protein) before and at 12 months after surgery. Local toxicity was assessed by the evaluation of signs of socket inflammation at the first postoperative month. Changes in implant size were determined by computed tomography scans at 2 and 12 months after surgery. RESULTS: The postoperative evaluations were uneventful. The biochemical evaluation showed no significant changes after surgery. None of the patients presented signs of orbital implant inflammation, infection, exposure, or extrusion. Computed tomography scan evaluations revealed no changes in implant size. CONCLUSION: To the best of our knowledge, this is the first phase-1 clinical study to certify the biocompatibility of the Fullcure resin for orbital implants in humans. The 3D printing technology permits fast and accurate production of implants for this purpose.


Subject(s)
Eye Evisceration/methods , Orbital Implants/standards , Polymers/standards , Printing, Three-Dimensional/standards , Adult , Biocompatible Materials/standards , Female , Humans , Male , Materials Testing , Middle Aged , Postoperative Period , Prosthesis Design , Reference Values , Reproducibility of Results , Time Factors , Treatment Outcome
7.
Article in English | MEDLINE | ID: mdl-29881640

ABSTRACT

BACKGROUND AND OBJECTIVES: Advances in neonatal care promoted increased survival rates of preterm infants, with a consequent increase in the number of children affected by retinopathy of prematurity (ROP). This study estimates the incidence of ROP and evaluates potential risk factors associated. METHODS: A retrospective cohort study of preterm infants born in a tertiary neonatal intensive care unit was conducted from March 2005 to August 2015. Six hundred and thirty-nine newborns were included based on the following criteria: infants born with less than 32 weeks' gestation or birth weight below 1500 g; or neonates born with 32-37 weeks' gestation or birth weight above 1500 g and any of the following associated: multiple gestation, respiratory distress syndrome, sepsis, blood transfusions or intraventricular hemorrhage. Neonates were followed up until disease resolution or until treatment criteria was achieved. RESULTS: A total of 602 newborns were evaluated after applying the exclusion criteria. Mean gestational age was 30.7 ± 2.5 weeks. The incidences of ROP at any stage and of type 1 prethreshold ROP were 33.9 and 5.0% respectively. Logistic regression analysis revealed that risk factors associated with ROP at any stage were extremely low birth weight (ELBW) (odds ratio [OR] = 3.10; 95% confidence interval [95% CI]:1.73-5.55), pulmonary diseases (OR = 2.49; 95% CI: 1.35-4.59), intraventricular hemorrhage (OR = 2.17; 95% CI: 1.10-4.30), and low gestational age (OR = 0.81; 95% CI: 0.73-0.91). The main risk factors associated with type 1 prethreshold ROP were pulmonary diseases (OR = 9.58; 95% CI: 1.27-72.04) and ELBW (OR = 3.66; 95% CI: 1.67-8.00). CONCLUSION: This study found a significant incidence of ROP (33.9%) in the studied population, and highlighted pulmonary diseases as a significant risk factor for type 1 prethreshold ROP.

8.
Ophthalmic Epidemiol ; 23(6): 354-359, 2016 12.
Article in English | MEDLINE | ID: mdl-27142891

ABSTRACT

PURPOSE: Trachoma, caused by the bacterium Chlamydia trachomatis, is a chronic, recurrent inflammatory disease that affects the cornea and conjunctiva. Trachoma is the leading infectious cause of avoidable blindness worldwide. Its prevalence is higher among individuals of low socioeconomic status, and trachoma is common in indigenous communities. The present study presents aspects of the epidemiological profile of trachoma in indigenous communities in Brazil. METHODS: We analyzed data from two databases collected during trachoma screening activities among the population of indigenous settlements in Brazil between 2000 and 2008. Trachoma cases were detected by ocular examination in accordance with the World Health Organization simplified trachoma grading system. RESULTS: According to the surveillance database, a total of 9582 individuals in six different states were examined. Among children aged 1-9 years, the prevalence of follicular trachomatous inflammation (TF) was 35.2%. In individuals aged ≥15 years, the prevalence of trachomatous trichiasis (TT) was 1.2% in individuals and the sex-specific prevalence was 0.8% in males and 1.6% in females (p = 0.02). In a survey of two states, 2301 indigenous schoolchildren were examined. In the age bracket 5-9 years, the prevalence of TF was 4.9 (95% confidence interval 3.8-6.0%). CONCLUSION: In Brazil, trachoma appears to be a serious public health problem in indigenous settlements, which should therefore be given priority in programs aimed at the elimination of trachoma in the country.


Subject(s)
Indians, South American/statistics & numerical data , Trachoma/ethnology , Trachoma/epidemiology , Adolescent , Age Distribution , Brazil/epidemiology , Child , Child, Preschool , Female , Health Surveys , Humans , Infant , Male , Population Surveillance , Prevalence , Sex Characteristics
9.
Arq Bras Oftalmol ; 78(4): 260-3, 2015.
Article in English | MEDLINE | ID: mdl-26375346

ABSTRACT

This literature review considers the treatment of an anophthalmic socket and the controversial aspects of the implants used to restore the lost volume after enucleation or evisceration, including the different materials employed and the main problems encountered during anophthalmic socket reconstruction. Since the 1980s, when integrated implants were proposed, there has been much controversy about what is the best implant for restoring the lost volume in an anophthalmic socket: integrated or non-integrated implants. Thus, we present this literature review to provide guidance to doctors and consumers.


Subject(s)
Anophthalmos/surgery , Eye Enucleation , Eye Evisceration , Ophthalmologic Surgical Procedures/methods , Orbit/surgery , Orbital Implants , Anophthalmos/classification , Humans
10.
Arq. bras. oftalmol ; 78(4): 260-263, July-Aug. 2015.
Article in English | LILACS | ID: lil-759252

ABSTRACT

ABSTRACTThis literature review considers the treatment of an anophthalmic socket and the controversial aspects of the implants used to restore the lost volume after enucleation or evisceration, including the different materials employed and the main problems encountered during anophthalmic socket reconstruction. Since the 1980s, when integrated implants were proposed, there has been much controversy about what is the best implant for restoring the lost volume in an anophthalmic socket: integrated or non-integrated implants. Thus, we present this literature review to provide guidance to doctors and consumers.


RESUMOEsta revisão da literatura abrange o tratamento da cavidade anoftálmica, assim como os controversos aspectos relacionados com os implantes de cavidade utilizados para recompor o volume perdido após enucleações ou eviscerações, tais como os diferentes materiais utilizados e os principais problemas enfrentados na reconstrução da cavidade anoftálmica. Depois dos anos 80 do século passado, quando foram introduzidos os implantes integrados, há muitas controvérsias sobre qual seria o melhor implante para recompor o volume perdido na cavidade anoftálmica: implante integrado ou não integrado? Desta forma, apresentamos esta revisão da literatura, que procura melhor orientar médicos e consumidores.


Subject(s)
Humans , Anophthalmos/surgery , Eye Enucleation , Eye Evisceration , Orbital Implants , Ophthalmologic Surgical Procedures/methods , Orbit/surgery , Anophthalmos/classification
11.
Ophthalmic Plast Reconstr Surg ; 28(6): 429-33, 2012.
Article in English | MEDLINE | ID: mdl-23138202

ABSTRACT

PURPOSE: One of the most common problems of the surgical management of Graves upper eyelid retraction is the occurrence of eyelid contour abnormalities. In the present study, the postoperative contour of a large sample of eyelids of patients with Graves orbitopathy was measured. METHODS: The postoperative upper eyelid contour of 62 eyes of 43 patients with Graves orbitopathy was subjectively classified by 3 experienced surgeons in 3 categories: poor, fair, and good. The shape of the eyelid contours in each category was then measured with a recently developed custom-made software by measuring multiple midpupil eyelid distances each 15° along the palpebral fissure. The upper eyelid contour of 60 normal subjects was also quantified as a control group. RESULTS: The mean ratio between the sum of the lateral and medial midpupil eyelid distances (lateral/medial ratio) was 1.10 ± 0.11 standard deviation in controls and 1.15 ± 0.13 standard deviation in patients. Postoperatively, the mean midpupil eyelid distance at 90° was 4.16 ± 1.13 mm standard deviation. The distribution lateral/medial ratios of the eyelids judged as having good contours was similar to the distribution of the controls with a modal value centered on the interval between 1.0 and 1.10. The distribution of lateral/medial ratios of the eyelids judged as having poor contour was bimodal, with eyelids with low and high lateral/medial ratios. Low lateral/medial ratios occurred when there was a lateral overcorrection, giving the eyelid a flat or a medial ptosis appearance. High lateral/medial ratios were due to a central or medial overcorrection or a lateral peak maintenance. CONCLUSIONS: Postoperative upper eyelid contour abnormalities can be quantified by comparing the sum of multiple midpupil eyelid distances of the lateral and medial sectors of the eyelid. Low and high lateral/medial ratios are anomalous and judged as unpleasant.


Subject(s)
Esthetics , Eyelid Diseases/surgery , Eyelids/pathology , Graves Ophthalmopathy/surgery , Oculomotor Muscles/surgery , Adolescent , Adult , Aged , Blepharoplasty , Eyelid Diseases/pathology , Female , Graves Ophthalmopathy/pathology , Humans , Male , Middle Aged , Postoperative Period , Preoperative Period , Young Adult
12.
Arq Bras Oftalmol ; 74(3): 207-8, 2011.
Article in English | MEDLINE | ID: mdl-21915449

ABSTRACT

Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Eyelid Neoplasms/drug therapy , Hemangioma, Capillary/drug therapy , Neoplastic Syndromes, Hereditary/drug therapy , Propranolol/therapeutic use , Female , Humans , Induction Chemotherapy/methods , Infant , Treatment Outcome
14.
Arq. bras. oftalmol ; 74(3): 207-208, May-June 2011. ilus
Article in English | LILACS | ID: lil-598316

ABSTRACT

Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.


Hemangiomas são os tumores benignos mais comuns durante o primeiro ano de vida. Apesar do seu curso autolimitado, os hemangiomas capilares podem prejudicar funções vitais ou sensoriais como a visão e causar alteração estética. O tratamento usual inclui esteróides orais ou intralesionais, interferon alfa, citotoxinas, laser e ressecção cirúrgica. Entretanto estes tratamentos não estão livres de complicações e efeitos adversos. Este relato descreve o caso de um bebê feminino de 3 meses com um hemangioma rapidamente progressivo na pálpebra superior esquerda, causando obstrução no eixo visual. O hemangioma respondeu rapidamente a uma baixa dose oral de propranolol. A resposta clínica foi notada poucos dias após o início do tratamento, com regressão a 1/4 do seu tamanho original após 45 dias de tratamento, e a menos de 1/10 após 8 meses, sem ter apresentado nenhum efeito adverso.


Subject(s)
Female , Humans , Infant , Adrenergic beta-Antagonists/therapeutic use , Eyelid Neoplasms/drug therapy , Hemangioma, Capillary/drug therapy , Neoplastic Syndromes, Hereditary/drug therapy , Propranolol/therapeutic use , Induction Chemotherapy/methods , Treatment Outcome
16.
Säo Paulo; s.n; 1999. 111 p. tab.
Thesis in Portuguese | LILACS | ID: lil-272365

ABSTRACT

Blefaroespasmo tem um componente motor caracterizado pelo espasmo do músculo orbicular e um componente sensorial cujo componente mais proeminente é a fotofobia. Esta fotofobia associada ao blefaroespasmo tem algumas similaridades com dores mantidas pelo sistema nervoso simpático, como por exemplo, a distrofia simpática reflexa. Pacientes com distrofia simpática reflexa tem redução nos seus sintomas após o bloqueio cervical simpático com anestésicos locais. Este estudo testa a hipótese da fotofobia do blefaroespasmo ser causada ou mantida pelo sistema nervoso simpático. Foram estudados dezenove pacientes com blefaroespasmo. Treze destes pacientes referiram melhora subjetiva nos sintomas do blefaroespasmo, e treze destes pacientes tiveram ainda evidência objetiva de diminuição do espasmo ocular provocado pelo estímulo luminoso após o bloqueio simpático cervical. Foi encontrada doença de superfície ocular (olho seco) em todos pacientes estudados, sugerindo a hipótese do blefaroespasmo ser mantido pelo sistema nervoso simpático com um filme lacriamal anormal. Especula-se sobre um possível circuito neurológico que possa explicar esta observação


Subject(s)
Blepharospasm , Sympathetic Nervous System
17.
Rev. bras. oftalmol ; 56(3): 187-93, mar. 1997. ilus, tab
Article in Portuguese | LILACS | ID: lil-189656

ABSTRACT

Penfigóide Ocular Cicatricial é uma doença crônica, progressiva e auto-imune das membranas mucosas. Neste estudo acompanhou-se 15 pacientes submetidos à terapia imunossupressora por um período médio de 13 meses. A resposta ao tratamento foi avaliada em relaçäo à diminuiçäo da atividade inflamatória e parada da progressäo da doença. O diagnóstico foi tardio: 69 por cento dos pacientes apresentaram visäo pior que 20/200 e 86 por cento estavam em estágios avançados da doença no exame inicial. Resposta clínica ao tratamento inicial com Dapsone foi observada na maioria dos pacientes. Em 3 casos foi necessária a substituiçäo por methotrexate. Em um paciente iniciou-se o tratamento com ciclofosfamida devido à intensidade inflamatória do quadro ocular. A imunodepressäo sistêmica é o tratamento de escolha para penfigóide, porém deve ser feita por médicos treinados, já que säo drogas potencialmente letais


Subject(s)
Humans , Adult , Middle Aged , Conjunctivitis/drug therapy , Immunosuppressive Agents/therapeutic use , Pemphigoid, Benign Mucous Membrane/drug therapy
18.
Arq. bras. oftalmol ; 59(1): 83-7, fev. 1996. tab
Article in Portuguese | LILACS | ID: lil-285324

ABSTRACT

Foi realizado um levamntamento sobre a prevalência de tracoma entre os habitantes do parque Indígena do Xingu, examinando-se as tribos Iaualapiti, Calapalo, Cuicuro, Matipu, Camaiurá e Uaurá no alto do Xingu, e Suiá, Caiabi, Juruna e Paraná no baixo Xingu. Foram examinados 1272 índios, sendo a prevalência total de tracoma na populaçäo examinada de 33, 8 por cento. Os Paranáapresentaram a maior prevalência, ou 75,2 por cento. as tribos do Alto Xingu apresentaram prevalências com diferenças näo estatisticamente significativas entre si, sendo a prevalência total de tracoma neste grupo de 35,6 por cento, semelhante à encontrada entre os Suiá, de 35,3 por cento. As mais baixas prevalências foram encontradas entre os Caiabi, com 18,3 por cento, e entre os Juruna, com 18,0 por cento. Näo foram encontrados casos de triquíase, entrópio, opacificaçäo de córnea ou baixa de acuidade visual provocada por tracoma.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Adult , Indians, South American , Trachoma/epidemiology , Brazil
19.
Arq. bras. oftalmol ; 56(6): 339-42, dez. 1993. ilus
Article in Portuguese | LILACS | ID: lil-134116

ABSTRACT

Säo apresentados cinco casos de "Floppy Eyelid Syndrome", com respectivas descriçöes clínicas e condutas terapêuticas. Faz-se uma ampla revisäo da literatura sobre o assunto e propöe-se o nome de "Síndrome da Flacidez da Pálpebra Superior" para ser adotado em nosso meio


Subject(s)
Humans , Male , Female , Middle Aged , Conjunctivitis, Allergic/etiology , Eyelids/abnormalities , Eyelid Diseases/etiology , Eyelid Diseases/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...